Outcomes Hematological parameters | Model 1 HR (95% CI) | Model 2 HR (95% CI) | C-statistica (AUC) | Relative IDIa (%) |
---|---|---|---|---|
Total CV events (n = 212) |  |  |  |  |
 Haemoglobin | 0.93 (0.80–1.08) | 0.98 (0.84–1.14) | – | – |
 RDW | 1.04 (0.91–1.19) | 1.05 (0.92–1.21) | – | – |
 Leukocytes | 1.19 (1.04–1.37)‡ | 1.07 (0.93–1.24) | – | – |
 Neutrophyls | 1.19 (1.04–1.36)‡ | 1.10 (0.96–1.26) | – | – |
 Lymphocytes | 0.99 (0.84–1.17) | 0.96 (0.80–1.14) | – | – |
 Monocytes | 1.18 (1.04–1.35)‡ | 1.10 (0.95–1.26) | – | – |
 Platelets | 1.14 (0.99–1.31) | 1.11 (0.96–1.29) | – | – |
 Neutrophyl-to-lymphocyte ratio | 1.15 (1.02–1.30)‡ | 1.10 (0.97–1.24) | – | – |
 Lymphocyte-to-monocyte ratio | 0.85 (0.72–1.01) | 0.89 (0.75–1.05) | – | – |
 Platelet-to-lymphocyte ratio | 1.07 (0.94–1.23) | 1.08 (0.94–1.25) | – | – |
 Monocyte-to-HDL ratio | 1.20 (1.05–1.37)†| 1.09 (0.94–1.26) | – | – |
Major CV events (n = 174) |  |  |  |  |
 Haemoglobin | 0.92 (0.78–1.08) | 0.93 (0.79–1.10) | – | – |
 RDW | 1.05 (0.91–1.21) | 1.06 (0.92–1.23) | – | – |
 Leukocytes | 1.19 (1.02–1.38)‡ | 1.07 (0.92–1.25) | – | – |
 Neutrophyls | 1.18 (1.02–1.37)‡ | 1.10 (0.96–1.27) | – | – |
 Lymphocytes | 0.96 (0.80–1.15) | 0.92 (0.76–1.11) | – | – |
 Monocytes | 1.20 (1.04–1.38)‡ | 1.10 (0.94–1.27) | – | – |
 Platelets | 1.13 (0.98–1.31) | 1.12 (0.97–1.29) | – | – |
 Neutrophyl-to-lymphocyte ratio | 1.17 (1.03–1.33)‡ | 1.13 (0.99–1.29) | – | – |
 Lymphocyte-to-monocyte ratio | 0.86 (0.71–1.03) | 0.90 (0.75–1.09) | – | – |
 Platelet-to-lymphocyte ratio | 1.07 (0.93–1.25) | 1.10 (0.94–1.28) | – | – |
 Monocyte-to-HDL ratio | 1.24 (1.07–1.43)†| 1.12 (0.96–1.31) | – | – |
CV mortality (n = 131) |  |  | 0.716 (0.668–0.765) |  |
 Haemoglobin | 0.93 (0.76–1.12) | 0.95 (0.78–1.16) | – | – |
 RDW | 1.15 (0.98–1.34) | 1.17 (0.99–1.38) | – | – |
 Leukocytes | 1.19 (0.99–1.41) | 1.10 (0.91–1.32) | – | – |
 Neutrophyls | 1.21 (1.03–1.44)‡ | 1.15 (0.97–1.36) | – | – |
 Lymphocytes | 0.87 (0.70–1.08) | 0.81 (0.64–1.02) | – | – |
Monocytes | 1.27 (1.08–1.50)†| 1.20 (1.01–1.44)‡ | 0.724§ | 15.5%§ |
 Platelets | 1.04 (0.87–1.25) | 1.02 (0.85–1.22) | – | – |
 Neutrophyl-to-lymphocyte ratio | 1.25 (1.08–1.44)†| 1.23 (1.06–1.43)†| 0.719§ | 9.3%§ |
 Lymphocyte-to-monocyte ratio | 0.72 (0.57–0.92)†| 0.74 (0.58–0.95)‡ | 0.725§ | 13.4%§ |
 Platelet-to-lymphocyte ratio | 1.08 (0.91–1.29) | 1.11 (0.93–1.33) | – | – |
 Monocyte-to-HDL ratio | 1.32 (1.12–1.56)* | 1.21 (1.01–1.46)‡ | 0.722§ | 15.5%§ |
All-cause mortality (n = 264) |  |  | 0.755 (0.717–0.793) |  |
 Haemoglobin | 0.86 (0.75–0.98) | 0.90 (0.78–1.03) | – | – |
 RDW | 1.08 (0.96–1.21) | 1.08 (0.96–1.22) | – | – |
 Leukocytes | 1.10 (0.97–1.25) | 1.04 (0.91–1.18) | – | – |
 Neutrophyls | 1.16 (1.03–1.31)‡ | 1.11 (0.98–1.25) | – | – |
 Lymphocytes | 0.80 (0.68–0.94)†| 0.77 (0.65–0.90)†| 0.756§ | 1.6%§ |
 Monocytes | 1.20 (1.07–1.35)†| 1.13 (0.99–1.28) | – | – |
 Platelets | 1.04 (0.91–1.18) | 1.02 (0.89–1.16) | – | – |
 Neutrophyl-to-lymphocyte ratio | 1.23 (1.11–1.37)* | 1.19 (1.07–1.33)* | 0.757§ | 2.6%§ |
 Lymphocyte-to-monocyte ratio | 0.69 (0.58–0.82)* | 0.72 (0.60–0.86)* | 0.763§ | 9.5%§ |
 Platelet-to-lymphocyte ratio | 1.17 (1.04–1.31)‡ | 1.17 (1.03–1.31)‡ | 0.756§ | 0.5%§ |
 Monocyte-to-HDL ratio | 1.21 (1.07–1.37)†| 1.11 (0.97–1.27) | – | – |